Kristi Jones - Net Worth and Insider Trading
Kristi Jones Net Worth
The estimated net worth of Kristi Jones is at least $731 dollars as of 2024-11-08. Kristi Jones is the President and CEO of NexImmune Inc and owns about 2,923 shares of NexImmune Inc (NEXI) stock worth over $731. Details can be seen in Kristi Jones's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kristi Jones has not made any transactions after 2022-03-29 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Kristi Jones
Kristi Jones Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kristi Jones owns 1 companies in total, including NexImmune Inc (NEXI) .
Click here to see the complete history of Kristi Jones’s form 4 insider trades.
Insider Ownership Summary of Kristi Jones
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
NEXI | NexImmune Inc | 2022-03-29 | Chief Operating Officer |
Kristi Jones Latest Holdings Summary
Kristi Jones currently owns a total of 1 stock. Kristi Jones owns 2,923 shares of NexImmune Inc (NEXI) as of March 29, 2022, with a value of $731.
Latest Holdings of Kristi Jones
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
NEXI | NexImmune Inc | 2022-03-29 | 2,923 | 0.25 | 731 |
Holding Weightings of Kristi Jones
Kristi Jones Form 4 Trading Tracker
According to the SEC Form 4 filings, Kristi Jones has made a total of 2 transactions in NexImmune Inc (NEXI) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in NexImmune Inc is the acquisition of 400 shares on March 29, 2022, which cost Kristi Jones around $37,400.
Insider Trading History of Kristi Jones
- 1
Kristi Jones Trading Performance
GuruFocus tracks the stock performance after each of Kristi Jones's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kristi Jones is -39.92%. GuruFocus also compares Kristi Jones's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kristi Jones within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Kristi Jones's insider trading performs compared to the benchmark.
Performance of Kristi Jones
Kristi Jones Ownership Network
Ownership Network List of Kristi Jones
Ownership Network Relation of Kristi Jones
Kristi Jones Owned Company Details
What does NexImmune Inc do?
Who are the key executives at NexImmune Inc?
Kristi Jones is the Chief Operating Officer of NexImmune Inc. Other key executives at NexImmune Inc include VP & Corporate Controller Timothy Stover , Chief Science Officer Mathias Oelke , and EVP of R&D Jerome B Zeldis .
NexImmune Inc (NEXI) Insider Trades Summary
Over the past 18 months, Kristi Jones made no insider transaction in NexImmune Inc (NEXI). Other recent insider transactions involving NexImmune Inc (NEXI) include a net sale of 7,825 shares made by Alan S. Roemer ,
In summary, during the past 3 months, insiders sold 0 shares of NexImmune Inc (NEXI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 7,825 shares of NexImmune Inc (NEXI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 7,825 shares.
NexImmune Inc (NEXI)'s detailed insider trading history can be found in Insider Trading Tracker table.
NexImmune Inc Insider Transactions
Kristi Jones Mailing Address
Above is the net worth, insider trading, and ownership report for Kristi Jones. You might contact Kristi Jones via mailing address: C/o Neximmune, Inc., 9119 Gaither Road, Gaithersburg Md 20877.